Teva's (TEVA) Milprosa" treatment proved to be "an effective and safe option" for supplementing...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Teva's (TEVA) Milprosa" treatment proved to be "an effective and safe option" for supplementing the progesterone hormone in women undergoing IVF treatment in a Phase III trial. The study is significant for Teva, "because fertility is a meaningful new area of specialization for the company and one in which a significant unmet need exists." Shares +0.2% in Tel Aviv. (PR)